NEW YORK CITY, New York: At the start of 2025, drug companies raised prices on over 250 brand-name medications in the U.S., including Pfizer's COVID-19 treatment Paxlovid, Bristol Myers Squibb's cancer therapies, and vaccines from Sanofi, according to healthcare research firm 3 Axis Advisors.
Most price increases were under 10 percent, with the median increase at 4.5 percent-similar to last year's average. Drugm
